Premium
Glibenclamide, a blocker of ATP‐sensitive potassium channels, reverses endotoxin‐induced hypotension in pig
Author(s) -
Vanelli G,
Hussain SN,
Aguggini G
Publication year - 1995
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/expphysiol.1995.sp003832
Subject(s) - glibenclamide , potassium channel , antagonist , blood pressure , atp sensitive potassium channel , potassium channel blocker , pharmacology , chemistry , anesthesia , medicine , endocrinology , receptor , diabetes mellitus
In anaesthetized, mechanically ventilated, indomethacin‐treated pigs, we infused E. coli endotoxin (LPS, 20 micrograms kg‐1 h‐1, i.v.). After 150 min of endotoxaemia, 10 mg kg‐1 glibenclamide (an ATP‐sensitive K+ channel antagonist) was administered i.v. over 5 min. Vascular variables were recorded before (control), after 150 min of endotoxaemia and 5, 15 and 30 min after glibenclamide infusion. Glibenclamide transiently (within 5 min) increased systemic arterial pressure, reduced by LPS administration, without an effect on cardiac output. Our data indicate that ATP‐sensitive K+ channels may play a partial role in the vascular changes due to endotoxaemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom